Kaifeng Lu, PhD

Executive Director
AbbVie
Madison, New Jersey

Disclosure information not submitted.

Presentation(s):

• Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study

  POSTER ABSTRACT